EIDB close up lab shot


SpFN First Dose


A unique vaccine to protect against COVID-19 begins Phase 1 clinical testing in early April at the at the Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center. Scientists developed a nanoparticle vaccine based on a ferritin platform that offers a flexible approach to target multiple variants of SARS-COV-2 and potentially other coronaviruses as well

Microscope image of Ebola virus

Hemorrhagic Fevers

Hemorrhagic fevers are a family of infectious diseases including Ebola, Marburg, Lassa fever and yellow fever that affect the body’s blood clotting abilities. Recent outbreaks have occurred in militarily strategic regions like West Africa where WRAIR’s research infrastructure has enabled surveillance and countermeasure research.